The DOI matches its Crossref record; 127 of the 127 references it cites were found in a registry or an index.
Extrahepatic Morbidity and Mortality of Chronic Hepatitis C
Open accessAbstract
Chronic hepatitis C virus (HCV) infection is associated with several extrahepatic manifestations. Patients with HCV may develop mixed cryoglobulinemia and its sequelae, ranging from cutaneous and visceral vasculitis to glomerulonephritis and B-cell non-Hodgkin lymphoma. HCV-infected patients have increased rates of insulin resistance, diabetes, and atherosclerosis, which may lead to increased cardiovascular morbidity and mortality. Neurological manifestations of HCV infection include fatigue and cognitive impairment. The mechanisms causing the extrahepatic effects of HCV infection are likely multifactorial and may include endocrine effects, HCV replication in extrahepatic cells, or a heightened immune reaction with systemic effects. Successful eradication of HCV with interferon alfa and ribavirin was shown to improve some of these extrahepatic effects; sustained virological response is associated with resolution of complications of cryoglobulinemia, reduced levels of insulin resistance, reduced incidence of diabetes and stroke, and improved fatigue and cognitive functioning. The availability of new interferon-free, well-tolerated anti-HCV treatment regimens is broadening the spectrum of patients available for therapy, including those in whom interferon was contraindicated, and will likely result in greater improvements in the extrahepatic manifestations of HCV. If these regimens are shown to confer significant benefit in the metabolic, cardiovascular, or neuropsychiatric conditions associated with HCV infection, extrahepatic manifestations of HCV may become a major indication for treatment even in the absence of liver disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inflammation and insulin resistance
Shoelson, S. E. (2006) · Journal of Clinical Investigation · doi:10.1172/jci29069 · Cited by 4,769
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
Self-citation. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
Kuller, L. H., Tracy, R., Belloso, W., Wit, S. D., Drummond, F., Lane, H. C., Ledergerber, B., Lundgren, J., Neuhaus, J., Nixon, D., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050203 · Cited by 1,617
van der Meer, A. J., Veldt, B. J., Feld, J. J., Wedemeyer, H., Dufour, J.-F., Lammert, F., Duarte-Rojo, A., Heathcote, E. J., Manns, M. P., Kuske, L., et al. (2012) · JAMA · doi:10.1001/jama.2012.144878 · Cited by 1,510
Self-citationPanel, A. H. G. (2015) · Hepatology · doi:10.1002/hep.27950 · Cited by 1,382
Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
Sulkowski, M. S., Gardiner, D. F., Rodriguez-Torres, M., Reddy, K. R., Hassanein, T., Jacobson, I., Lawitz, E., Lok, A. S., Hinestrosa, F., Thuluvath, P. J., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1306218 · Cited by 1,190
Self-citationEASL Recommendations on Treatment of Hepatitis C 2015
(2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.025 · Cited by 1,156
Hermine, O., Lefrère, F., Bronowicki, J.-P., Mariette, X., Jondeau, K., Eclache-Saudreau, V., Delmas, B., Valensi, F., Cacoub, P., Brechot, C., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa013376 · Cited by 807
Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
Zeuzem, S., Dusheiko, G. M., Salupere, R., Mangia, A., Flisiak, R., Hyland, R. H., Illeperuma, A., Svarovskaia, E., Brainard, D. M., Symonds, W. T., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316145 · Cited by 795
Shiratori, Y., Imazeki, F., Moriyama, M., Yano, M., Arakawa, Y., Yokosuka, O., Kuroki, T., Nishiguchi, S., Sata, M., Yamada, G., et al. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-7-200004040-00002 · Cited by 733
Romero-Gómez, M., Del Mar Viloria, M., Andrade, R. J., Salmerón, J., Diago, M., Fernández-Rodríguez, C. M., Corpas, R., Cruz, M., Grande, L., Vázquez, L., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.12.049 · Cited by 732
Insulin resistance is associated with chronic hepatitis C and virus infection fibrosis progression
Hui, J. M., Sud, A., Farrell, G. C., Bandara, P., Byth, K., Kench, J. G., McCaughan, G. W., & George, J. (2003) · Gastroenterology · doi:10.1053/j.gastro.2003.08.032 · Cited by 718
ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV
Ferenci, P., Bernstein, D., Lalezari, J., Cohen, D., Luo, Y., Cooper, C., Tam, E., Marinho, R. T., Tsai, N., Nyberg, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1402338 · Cited by 693
Mehta, S. H., Brancati, F. L., Sulkowski, M. S., Strathdee, S. A., Szklo, M., & Thomas, D. L. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-8-200010170-00009 · Cited by 676
Self-citationVeldt, B. J., Heathcote, E. J., Wedemeyer, H., Reichen, J., Hofmann, W. P., Zeuzem, S., Manns, M. P., Hansen, B. E., Schalm, S. W., & Janssen, H. L. A. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-10-200711200-00003 · Cited by 602
Self-citationPrevalence of HIV, hepatitis B, and hepatitis C in people with severe mental illness
(2001) · American Journal of Public Health · doi:10.2105/ajph.91.1.31 · Cited by 589 · cited 1×
“This is partly related to the higher incidence of risk behaviors among persons with psychiatric disorders that can result in HCV exposure and increased alcohol use.(79) However, emerging literature demonstrates that HCV is also associated with an increased prevalence of neuropsychiatric symptoms, independent of preexi…”
BackgroundFoster, G. R., Goldin, R. D., & Thomas, H. C. (1998) · Hepatology · doi:10.1002/hep.510270132 · Cited by 562
Lee, M.-H., Yang, H.-I., Lu, S.-N., Jen, C.-L., You, S.-L., Wang, L.-Y., Wang, C.-H., Chen, W. J., Chen, C.-J., & for the R.E.V.E.A.L.-HCV Study Group (2012) · Journal of Infectious Diseases · doi:10.1093/infdis/jis385 · Cited by 554
Lawitz, E., Poordad, F. F., Pang, P. S., Hyland, R. H., Ding, X., Mo, H., Symonds, W. T., McHutchison, J. G., & Membreno, F. E. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62121-2 · Cited by 547
Moucari, R., Asselah, T., Cazals–Hatem, D., Voitot, H., Boyer, N., Ripault, M., Sobesky, R., Martinot–Peignoux, M., Maylin, S., Nicolas–Chanoine, M., et al. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.11.010 · Cited by 546
Kim, C.-S., Park, H.-S., Kawada, T., Kim, J.-H., Lim, D., Hubbard, N. E., Kwon, B.-S., Erickson, K. L., & Yu, R. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803259 · Cited by 511
Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis
White, D. L., Ratziu, V., & El-Serag, H. B. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.006 · Cited by 451
Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease
Forton, D. M., Thomas, H. C., Murphy, C. A., Allsop, J. M., Foster, G. R., Main, J., Wesnes, K. A., & Taylor-Robinson, S. D. (2002) · Hepatology · doi:10.1053/jhep.2002.30688 · Cited by 450
Self-citationWichers, M. C., Koek, G. H., Robaeys, G., Verkerk, R., Scharpé, S., & Maes, M. (2005) · Molecular Psychiatry · doi:10.1038/sj.mp.4001600 · Cited by 445
Hepatitis C Virus Infection and Incident Type 2 Diabetes
Mehta, S. H., Brancati, F. L., Strathdee, S. A., Pankow, J. S., Netski, D., Coresh, J., Szklo, M., & Thomas, D. L. (2003) · Hepatology · doi:10.1053/jhep.2003.50291 · Cited by 404
Andreone, P., Colombo, M. G., Enejosa, J. V., Koksal, I., Ferenci, P., Maieron, A., Müllhaupt, B., Horsmans, Y., Weiland, O., Reesink, H. W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.04.045 · Cited by 365
Aytug, S., Reich, D., Sapiro, L. E., Bernstein, D., & Begum, N. (2003) · Hepatology · doi:10.1016/j.hep.2003.09.012 · Cited by 340
Cardoso, A.-C., Moucari, R., Figueiredo-Mendes, C., Ripault, M.-P., Giuily, N., Castelnau, C., Boyer, N., Asselah, T., Martinot-Peignoux, M., Maylin, S., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.12.028 · Cited by 333
Evidence for a cerebral effect of the hepatitis C virus
Forton, D. M., Allsop, J. M., Main, J., Foster, G. R., Thomas, H. C., & Taylor-Robinson, S. D. (2001) · The Lancet · doi:10.1016/s0140-6736(00)05270-3 · Cited by 333
Self-citationNeuropsychological impairment in patients with chronic hepatitis C
Hilsabeck, R. C., Perry, W., & Hassanein, T. I. (2002) · Hepatology · doi:10.1053/jhep.2002.31257 · Cited by 288
Straczkowski, M., Dzienis-Straczkowska, S., Stêpieñ, A., Kowalska, I., Szelachowska, M., & Kinalska, I. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-020135 · Cited by 280
Hsu, Y.-C., Lin, J.-T., Ho, H. J., Kao, Y.-H., Huang, Y.-T., Hsiao, N.-W., Wu, M.-S., Liu, Y.-Y., & Wu, C.-Y. (2014) · Hepatology · doi:10.1002/hep.26892 · Cited by 277
Sustained virological response reduces incidence of onset of type 2 diabetes in chronic hepatitis C†
Arase, Y., Suzuki, F., Suzuki, Y., Akuta, N., Kobayashi, M., Kawamura, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Hirakawa, M., et al. (2009) · Hepatology · doi:10.1002/hep.22703 · Cited by 265
Kawaguchi, T., Ide, T., Taniguchi, E., Hirano, E., Itou, M., Sumie, S., Nagao, Y., Yanagimoto, C., Hanada, S., Koga, H., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.01038.x · Cited by 254
Weissenborn, K., Krause, J., Bokemeyer, M., Hecker, H., Schüler, A., Ennen, J. C., Ahl, B., Manns, M. P., & Böker, K. W. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2004.07.022 · Cited by 250
Self-citationHepatitis C Virus Infects the Endothelial Cells of the Blood-Brain Barrier
Fletcher, N. F., Wilson, G. K., Murray, J., Hu, K., Lewis, A., Reynolds, G. M., Stamataki, Z., Meredith, L. W., Rowe, I. A., Luo, G., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.11.028 · Cited by 249
Fatigue in patients with chronic hepatitis C
Poynard, T., Cacoub, P., Ratziu, V., Myers, R. P., Dezailles, M. H., Mercadier, A., Ghillani, P., Charlotte, F., Piette, J. C., Moussalli, J., et al. (2002) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2002.00364.x · Cited by 247
Forton, D. M., Karayiannis, P., Mahmud, N., Taylor-Robinson, S. D., & Thomas, H. C. (2004) · Journal of Virology · doi:10.1128/jvi.78.10.5170-5183.2004 · Cited by 242
Self-citationCerebral metabolite abnormalities correlate with clinical severity of HIV-1 cognitive motor complex
Chang, L., Ernst, T., Leonido-Yee, M., Walot, I., & Singer, E. (1999) · Neurology · doi:10.1212/wnl.52.1.100 · Cited by 235
Hepatitis C infection, antiviral treatment and mental health: A European expert consensus statement
Schaefer, M., Capuron, L., Friebe, A., Diez-Quevedo, C., Robaeys, G., Neri, S., Foster, G. R., Kautz, A., Forton, D., & Pariante, C. M. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.037 · Cited by 225
Self-citationHsu, Y.-C., Ho, H. J., Huang, Y.-T., Wang, H.-H., Wu, M.-S., Lin, J.-T., & Wu, C.-Y. (2015) · Gut · doi:10.1136/gutjnl-2014-308163 · Cited by 214
Charles, E. D., Brunetti, C., Marukian, S., Ritola, K. D., Talal, A. H., Marks, K., Jacobson, I. M., Rice, C. M., & Dustin, L. B. (2011) · Blood · doi:10.1182/blood-2010-10-312942 · Cited by 206
Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C
Hilsabeck, R. C., Hassanein, T. I., Carlson, M. D., Ziegler, E. A., & Perry, W. (2003) · Journal of the International Neuropsychological Society · doi:10.1017/s1355617703960048 · Cited by 205
McAndrews, M. P., Farcnik, K., Carlen, P., Damyanovich, A., Mrkonjic, M., Jones, S., & Heathcote, E. J. (2005) · Hepatology · doi:10.1002/hep.20635 · Cited by 197
Hepatitis C Virus Neuroinvasion: Identification of Infected Cells
Wilkinson, J., Radkowski, M., & Laskus, T. (2009) · Journal of Virology · doi:10.1128/jvi.01890-08 · Cited by 196
Arase, Y., Kobayashi, M., Suzuki, F., Suzuki, Y., Kawamura, Y., Akuta, N., Kobayashi, M., Sezaki, H., Saito, S., Hosaka, T., et al. (2013) · Hepatology · doi:10.1002/hep.26087 · Cited by 191
Romero-Gómez, M., Fernández-Rodríguez, C. M., Andrade, R. J., Diago, M., Alonso, S., Planas, R., Solá, R., Pons, J. A., Salmerón, J., Barcena, R., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.11.022 · Cited by 185
Chronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosis
Adinolfi, L. E., Restivo, L., Zampino, R., Guerrera, B., Lonardo, A., Ruggiero, L., Riello, F., Loria, P., & Florio, A. (2012) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2012.01.051 · Cited by 185
Poustchi, H., Negro, F., Hui, J. M., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.07.026 · Cited by 179
Self-citationTherapy for Hepatitis C Virus–Related Cryoglobulinemic Vasculitis
Dammacco, F., & Sansonno, D. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208642 · Cited by 178
Vassalle, C., Masini, S., Bianchi, F., & Zucchelli, G. C. (2004) · Heart · doi:10.1136/hrt.2003.018937 · Cited by 178
Manifestations of Chronic Hepatitis C Virus Infection Beyond the Liver
Jacobson, I. M., Cacoub, P., Dal Maso, L., Harrison, S. A., & Younossi, Z. M. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2010.08.026 · Cited by 174
Lecube, A. (2006) · Diabetes Care · doi:10.2337/diacare.2951096 · Cited by 168
Wang, C.-S., Wang, S.-T., Yao, W.-J., Chang, T.-T., & Chou, P. (2007) · American Journal of Epidemiology · doi:10.1093/aje/kwm061 · Cited by 166
Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients
MUZZI, A., LEANDRO, G., RUBBIABRANDT, L., JAMES, R., KEISER, O., MALINVERNI, R., DUFOUR, J., HELBLING, B., HADENGUE, A., & GONVERS, J. (2005) · Journal of Hepatology · doi:10.1016/j.jhep.2004.09.022 · Cited by 165
Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia
Charles, E. D., Green, R. M., Marukian, S., Talal, A. H., Lake-Bakaar, G. V., Jacobson, I. M., Rice, C. M., & Dustin, L. B. (2008) · Blood · doi:10.1182/blood-2007-07-101717 · Cited by 164
Younossi, Z. M., Stepanova, M., Afdhal, N., Kowdley, K. V., Zeuzem, S., Henry, L., Hunt, S. L., & Marcellin, P. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.014 · Cited by 164
Associations of chronic hepatitis C with metabolic and cardiac outcomes
Younossi, Z. M., Stepanova, M., Nader, F., Younossi, Z., & Elsheikh, E. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12234 · Cited by 162
Targher, G., Bertolini, L., Padovani, R., Rodella, S., Arcaro, G., & Day, C. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.021 · Cited by 162
Proinflammatory Cytokines, Insulin Resistance, and Insulin Secretion in Chronic Hepatitis C patients
Lecube, A., Hernández, C., Genescà, J., & Simó, R. (2006) · Diabetes Care · doi:10.2337/dc05-2509 · Cited by 161
Hepatitis C Virus Infection and Increased Risk of Cerebrovascular Disease
Lee, M.-H., Yang, H.-I., Wang, C.-H., Jen, C.-L., Yeh, S.-H., Liu, C.-J., You, S.-L., Chen, W. J., & Chen, C.-J. (2010) · Stroke · doi:10.1161/strokeaha.110.598136 · Cited by 160
Saadoun, D., Sellam, J., Ghillani-Dalbin, P., Crecel, R., Piette, J.-C., & Cacoub, P. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2101 · Cited by 160
Vanni, E., Abate, M. L., Gentilcore, E., Hickman, I., Gambino, R., Cassader, M., Smedile, A., Ferrannini, E., Rizzetto, M., Marchesini, G., et al. (2009) · Hepatology · doi:10.1002/hep.23031 · Cited by 158
Gisbert, J. P., García-Buey, L., Pajares, J. M., & Moreno‐Otero, R. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00346-5 · Cited by 154
Weißenborn, K., Ennen, J. C., Bokemeyer, M., Ahl, B., Wurster, U., Hl, T., Trebst, C., Hecker, H., & Berding, G. (2006) · Gut · doi:10.1136/gut.2005.080267 · Cited by 154
Pham, T. N. Q., King, D., MacParland, S. A., McGrath, J., Reddy, S. B., Bursey, F. R., & Michalak, T. I. (2008) · Gastroenterology · doi:10.1053/j.gastro.2007.12.011 · Cited by 148
Dai, C., Chuang, W., Ho, C., Hsieh, M., Huang, J., Lee, L., Hou, N., Lin, Z., Chen, S., Hsieh, M., et al. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.016 · Cited by 144
Cerebral microglial activation in patients with hepatitis c: in vivo evidence of neuroinflammation
Grover, V. P. B., Pavese, N., Koh, S., Wylezinska, M., Saxby, B. K., Gerhard, A., Forton, D. M., Brooks, D. J., Thomas, H. C., & Taylor-Robinson, S. D. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01510.x · Cited by 139
Self-citationYounossi, Z. M., Stepanova, M., Marcellin, P., Afdhal, N. H., Kowdley, K. V., Zeuzem, S., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.27724 · Cited by 138
Chronic Hepatitis C Is Associated With Peripheral Rather Than Hepatic Insulin Resistance
Milner, K., van der Poorten, D., Trenell, M. I., Jenkins, A. B., Xu, A., Smythe, G. A., Dore, G. J., Zekry, A., Weltman, M., Fragomeli, V., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.11.050 · Cited by 138
Autoimmunity and extrahepatic manifestations in hepatitis C virus infection
Manns, M. P., & Rambusch, E. G. (1999) · Journal of Hepatology · doi:10.1016/s0168-8278(99)80372-9 · Cited by 134
Self-citationIncreased All-Cause, Liver, and Cardiac Mortality among Hepatitis C Virus-seropositive Blood Donors
Guiltinan, A. M., Kaidarova, Z., Custer, B., Orland, J., Strollo, A. M., Cyrus, S., Busch, M. P., & Murphy, E. L. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwm370 · Cited by 133
Carotid atherosclerosis and chronic hepatitis C: A prospective study of risk associations
Petta, S., Torres, D., Fazio, G., Cammà, C., Cabibi, D., Marco, V. D., Licata, A., Marchesini, G., Mazzola, A., Parrinello, G., et al. (2011) · Hepatology · doi:10.1002/hep.25508 · Cited by 132
Self-citationGragnani, L., Fognani, E., Piluso, A., Boldrini, B., Urraro, T., Fabbrizzi, A., Stasi, C., Ranieri, J., Monti, M., Arena, U., et al. (2014) · Hepatology · doi:10.1002/hep.27623 · Cited by 132
Hepatitis B and C virus infection and the risk of atherosclerosis in a general population
Völzke, H., Schwahn, C., Wolff, B., Mentel, R., Robinson, D. M., Kleine, V., Felix, S. B., & John, U. (2004) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.01.010 · Cited by 129
Viral Elimination Reduces Incidence of Malignant Lymphoma in Patients with Hepatitis C
Kawamura, Y., Ikeda, K., Arase, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Akuta, N., Kobayashi, M., Suzuki, F., Suzuki, Y., et al. (2007) · The American Journal of Medicine · doi:10.1016/j.amjmed.2007.06.022 · Cited by 127
Hepatitis C , porphyria cutanea tarda and liver iron: an update
Caballes, F. R., Sendi, H., & Bonkovsky, H. L. (2012) · Liver International · doi:10.1111/j.1478-3231.2012.02794.x · Cited by 125
Letendre, S. L., Cherner, M., Ellis, R. J., Marquie‐Beck, J., Gragg, B., Marcotte, T. D., Heaton, R. K., McCutchan, J. A., & Grant, I. (2005) · AIDS · doi:10.1097/01.aids.0000192073.18691.ff · Cited by 122
Does Hepatitis C Virus Infection Increase Risk for Stroke? A Population-Based Cohort Study
Liao, C., Su, T., Sung, F.-C., Chou, W.-H., & Chen, T.-L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031527 · Cited by 119
Cerebral immune activation in chronic hepatitis C infection: A magnetic resonance spectroscopy study
Forton, D. M., Hamilton, G., Allsop, J. M., Grover, V. P. B., Wesnes, K. A., O’Sullivan, C. P., Thomas, H. C., & Taylor-Robinson, S. D. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.03.022 · Cited by 118
Self-citationImpact of treatment on extra hepatic manifestations in patients with chronic hepatitis C
Cacoub, P., Ratziu, V., Myers, R. P., Ghillani‐Dalbin, P., Piette, J. C., Moussalli, J., & Poynard, T. (2002) · Journal of Hepatology · doi:10.1016/s0168-8278(02)00067-3 · Cited by 118
Hsu, C., Kao, J., Chao, Y., Lin, H., Fan, Y.-C., Huang, C.-C., & Tsai, P. (2013) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12391 · Cited by 118
Activation of brain macrophages/microglia cells in hepatitis C infection
Wilkinson, J., Radkowski, M., Eschbacher, J. M., & Laskus, T. (2010) · Gut · doi:10.1136/gut.2009.199356 · Cited by 118
Hsu, C., Liu, C., Liu, C., Wang, C., Chen, C., Lai, M., Chen, P., Kao, J., & Chen, D. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01626.x · Cited by 113
Evidence for neuroinflammation and neuroprotection in HCV infection-associated encephalopathy
Bokemeyer, M., Ding, X.-Q., Goldbecker, A., Raab, P., Heeren, M., Arvanitis, D., Tillmann, H. L., Lanfermann, H., & Weißenborn, K. (2010) · Gut · doi:10.1136/gut.2010.217976 · Cited by 110
Meta‐analysis: insulin resistance and sustained virological response in hepatitis C
Eslam, M., Aparcero, R., Kawaguchi, T., Campo, J. A. D., Sata, M., Khattab, M. A., & Romero‐Gómez, M. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04716.x · Cited by 107
Hepatitis C virus and the brain
Fletcher, N. F., & McKeating, J. A. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2012.01591.x · Cited by 106
Alyan, Ö., Kaçmaz, F., Özdemır, Ö., Deveci, B., Astan, R., Çelebi, S., & İlkay, E. (2008) · Circulation Journal · doi:10.1253/circj.cj-08-0459 · Cited by 105
Mooren-type Hepatitis C Virus-associated Corneal Ulceration
Wilson, S. E., Lee, W. M., Murakami, C. S., Weng, J., & Moninger, G. A. (1994) · Ophthalmology · doi:10.1016/s0161-6420(94)31291-7 · Cited by 101
Hassanein, T., Cooksley, G., Sulkowski, M., Smith, C. I., Marinos, G., Lai, M., Pastore, G., Trejo-Estrada, R., Vale, A. M. H. E., Wintfeld, N., et al. (2004) · Journal of Hepatology · doi:10.1016/j.jhep.2003.12.014 · Cited by 101
Self-citationNo Association between Hepatitis C Virus Seropositivity and Acute Myocardial Infarction
Arcari, C. M., Nelson, K. E., Netski, D. M., Nieto, F. J., & Gaydos, C. A. (2006) · Clinical Infectious Diseases · doi:10.1086/507031 · Cited by 99
Metabolic and cardiovascular risk profiles and hepatitis C virus infection in rural Egypt
Marzouk, D., Jun, S. A. S. S., Bakr, I., El‐Hoseiny, M., Abdel-Hamid, M., Rekacewicz, C., Chaturvedi, N., Mohamed, M. K., & Fontanet, A. L. (2006) · Gut · doi:10.1136/gut.2006.091983 · Cited by 97
Younossi, Z. M., Stepanova, M., Henry, L. L., Gane, E. J., Jacobson, I. M., Lawitz, E., Nelson, D. R., Nader, F., & Hunt, S. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.12.006 · Cited by 97
Aghemo, A., Prati, G. M., Rumi, M. G., Soffredini, R., D’Ambrosio, R., Orsi, E., Nicola, S. D., Degasperi, E., Grancini, V., & Colombo, M. (2012) · Hepatology · doi:10.1002/hep.25867 · Cited by 95
Fattovich, G., Covolo, L., Bibert, S., Askarieh, G., Lagging, M., Clément, S., Malerba, G., Pasino, M., Guido, M., Puoti, M., et al. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04635.x · Cited by 94
Self-citationTsochatzis, E. A., Papatheodoridis, G., Hadziyannis, E. S., Georgiou, A. N., Kafiri, G., TINIAKOS, D. G., Manesis, E. K., & Archimandritis, A. J. (2008) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365520802085387 · Cited by 92
The new paradigm of hepatitis C therapy: integration of oral therapies into best practices
Afdhal, N. H., Zeuzem, S., Schooley, R. T., Thomas, D. L., Ward, J. W., Litwin, A. H., Razavi, H. A., Castéra, L., Poynard, T., Muir, A. J., et al. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12173 · Cited by 90
Self-citationExtrahepatic Manifestations and Autoantibodies in Patients with Hepatitis C Virus Infection
Himoto, T., & Masaki, T. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/871401 · Cited by 89
Relationship of hepatitis C virus infection with diabetes in the U.S. population
Ruhl, C. E., Menke, A., Cowie, C. C., & Everhart, J. E. (2014) · Hepatology · doi:10.1002/hep.27047 · Cited by 88
Myocardial injury in patients with chronic hepatitis C infection
Maruyama, S., Koda, M., Oyake, N., Sato, H., Fujii, Y., Horie, Y., & Murawaki, Y. (2012) · Journal of Hepatology · doi:10.1016/j.jhep.2012.07.045 · Cited by 87
Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin
KRAUS, M., Schafer, A., WISMANN, S., REIMER, P., & Scheurlen, M. (2005) · Clinical Pharmacology & Therapeutics · doi:10.1016/j.clpt.2004.09.007 · Cited by 79
Khattab, M. A., Eslam, M., Sharwae, M. A., Shatat, M., Ali, A., & Hamdy, L. (2010) · The American Journal of Gastroenterology · doi:10.1038/ajg.2010.110 · Cited by 79
Hepatitis C virus enhances incidence of idiopathic pulmonary fibrosis
Arase, Y., Suzuki, F., Suzuki, Y., Akuta, N., Kobayashi, M., Kawamura, Y., Yatsuji, H., Sezaki, H., Hosaka, T., Hirakawa, M., et al. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5880 · Cited by 79
Stefanova-Petrova, D. V., Tzvetanska, A. H., Naumova, E. J., Mihailova, A. P., Hadjiev, E. A., Dikova, R. P., Vukov, M. I., & Tchernev, K. G., Jr. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.13.6518 · Cited by 78
Rasenack, J. W. F., Zeuzem, S., Feinman, S. V., Heathcote, E. J., Manns, M. P., Yoshida, E. M., Swain, M. G., Gane, E. J., Moisés Diago, M., Revicki, D. A., et al. (2003) · PharmacoEconomics · doi:10.2165/00019053-200321050-00005 · Cited by 77
Self-citationCardiovascular diseases and HCV infection: a simple association or more?
Petta, S., Macaluso, F. S., & Craxì, A. (2013) · Gut · doi:10.1136/gutjnl-2013-306102 · Cited by 76
Self-citationForde, K. A., Haynes, K., Troxel, A. B., Trooskin, S. B., Osterman, M. T., Kimmel, S. E., Lewis, J. D., & Re, V. L. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01545.x · Cited by 74
Serfaty, L., Forns, X., Goeser, T., Ferenci, P., Nevens, F., Carosi, G., Drenth, J. P. H., Lonjon‐Domanec, I., DeMasi, R. A., Picchio, G., et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300749 · Cited by 73
Pruritus as a Presenting Symptom of Chronic Hepatitis C
Chia, S.-C., Bergasa, N. V., Kleiner, D. E., Goodman, Z., Hoofnagle, J. H., & Bisceglie, A. M. D. (1998) · Digestive Diseases and Sciences · doi:10.1023/a:1026646017851 · Cited by 70
Hsu, Y., Muo, C., Liu, C., Tsai, W., Hsu, C., Sung, F., & Kao, C. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.09.022 · Cited by 68
Chemerin, vaspin and insulin resistance in chronic hepatitis C
Kukla, M., Żwirska-Korczala, K., Gabriel, A., Waluga, M., Warakomska, I., Szczygieł, B., Berdowska, A., Mazur, W., Woźniak-Grygiel, E., & Kryczka, W. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01224.x · Cited by 67
Younossi, Z. M., & Henry, L. L. (2014) · Digestive and Liver Disease · doi:10.1016/j.dld.2014.09.025 · Cited by 62
Current understanding of insulin resistance in hepatitis C
Kaddai, V., & Negro, F. (2011) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.11.43 · Cited by 59
Self-citationQuality of life in patients with various liver diseases
Tillmann, H. L., Wiese, M., Braun, Y., Wiegand, J., Tenckhoff, S., Mössner, J., Manns, M. P., & Weißenborn, K. (2010) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2010.01292.x · Cited by 57
Self-citationHarrison, S. A., Hamzeh, F. M., Han, J., Pandya, P., Sheikh, M. Y., & Vierling, J. M. (2012) · Hepatology · doi:10.1002/hep.25661 · Cited by 57
Improvement of Neurocognitive Function in Responders to an Antiviral Therapy for Chronic Hepatitis C
Kraus, M. R., Schäfer, A., Teuber, G., Porst, H., Sprinzl, K., Wollschlaeger, S. W., Keicher, C., & Scheurlen, M. (2013) · Hepatology · doi:10.1002/hep.26229 · Cited by 56
Cerebral Glucose Utilisation in Hepatitis C Virus Infection-Associated Encephalopathy
Heeren, M., Weißenborn, K., Arvanitis, D. A., Bokemeyer, M., Goldbecker, A., Tountopoulou, A., Peschel, T., Großkreutz, J., Hecker, H., Buchert, R., et al. (2011) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2011.82 · Cited by 43
Pruritus as a symptom of hepatitis C
Fisher, D. A., & Wright, T. L. (1994) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(94)70072-9 · Cited by 39
Santer, D. M., Ma, M. M., Hockman, D. J., Landi, A., Tyrrell, D. L., & Houghton, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068308 · Cited by 38
Carotid and Femoral Atherosclerosis in Chronic Hepatitis C: A 5-Year Follow-Up
Bilora, F., Campagnolo, E., Rinaldi, R., Rossato, A., Arzenton, M., & Petrobelli, F. (2008) · Angiology · doi:10.1177/0003319707311536 · Cited by 36
TyG index, HOMA score and viral load in patients with chronic hepatitis C due to genotype 1
Petta, S., Marco, V. D., Stefano, R. D., et al. (2011) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01439.x · Cited by 30
Eradicating hepatitis C virus ameliorates insulin resistance without change in adipose depots
Milner, K. ‐., Jenkins, A. B., Trenell, M. I., Tid-Ang, J. D., Samocha‐Bonet, D., Weltman, M., Xu, A., George, J., & Chisholm, D. J. (2013) · Journal of Viral Hepatitis · doi:10.1111/jvh.12143 · Cited by 24
Burman, B. E., Bacchetti, P., Ayala, C. E., Gelman, N. O., Melgar, J., & Khalili, M. (2014) · Liver International · doi:10.1111/liv.12676 · Cited by 23
Saad, Y., Ahmed, A., Saleh, D. A., & Doss, W. H. (2013) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e32835f2726 · Cited by 22
Chronic HCV infection increases cardiac left ventricular mass index in normotensive patients
Perticone, M., Miceli, S., Maio, R., Caroleo, B., Sciacqua, A., Tassone, E. J., Greco, L., Staltari, O., Sesti, G., & Perticone, F. (2014) · Journal of Hepatology · doi:10.1016/j.jhep.2014.05.032 · Cited by 17
Spiegel, B. M. R., Younossi, Z. M., Hays, R. D., Revicki, D., Robbins, S., & Kanwal, F. (2005) · Hepatology · doi:10.1002/hep.20659 · Cited by 7
Ling, V., Mortimore, M., & Serisier, D. J. (2013) · SpringerPlus · doi:10.1186/2193-1801-2-101 · Cited by 5
Cited by
EASL Recommendations on Treatment of Hepatitis C 2018
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.026 · Cited by 2,827
Self-citationBlach, S., Zeuzem, S., Manns, M., Altraif, I., Duberg, A.-S., Muljono, D. H., Waked, I., Alavian, S. M., Lee, M.-H., Negro, F., et al. (2017) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(16)30181-9 · Cited by 2,006
Self-citationEASL recommendations on treatment of hepatitis C: Final update of the series☆
Pawlotsky, J.-M., Negro, F., Aghemo, A., Berenguer, M., Dalgard, O., Dusheiko, G., Marra, F., Puoti, M., & Wedemeyer, H. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.08.018 · Cited by 1,252
Self-citationEASL Recommendations on Treatment of Hepatitis C 2016
(2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.09.001 · Cited by 985
Nahon, P., Bourcier, V., Layese, R., Audureau, E., Cagnot, C., Marcellin, P., Guyader, D., Fontaine, H., Larrey, D., De Lédinghen, V., et al. (2017) · Gastroenterology · doi:10.1053/j.gastro.2016.09.009 · Cited by 538
Metadata
- Authors
- Negro, F., Forton, D., Craxì, A., Sulkowski, M. S., Feld, J. J., & Manns, M. P.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2015-11
- Volume
- 149
- Issue
- 6
- Pages
- 1345-1360
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2139773897
- Cited by
- 361
- References
- 127
- FWCI
- 23.88
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.